Anest. intenziv. Med. 2018;29(1):23-32

Selected aspects of the management of the brain-dead organ donorIntesive Care Medicine - Review Article

L. Kielberger1,2,*, J. Beneš2,3
1 1. interní klinika, Lékařská fakulta v Plzni, Univerzita Karlova
2 Biomedicínské centrum, Lékařská fakulta v Plzni, Univerzita Karlova
3 Klinika anesteziologie, resuscitace a intenzivní medicíny, Lékařská fakulta v Plzni, Univerzita Karlova

Transplantation medicine is undergoing an extraordinary progress nowadays. The number of organ transplants has been permanently increasing. The organ donation program represents a cornerstone of transplantation medicine. The majority of organs for transplantation in the Czech Republic is harvested from brain-dead donors. The legislative and organisational framework has been defined by the Transplantation Act and related documents. In this atricle we review the basics of brain death pathofysiology, brain death diagnostics and the complex management of the organ donor in intensive care units.

Keywords: organ donor; organ transplantation; brain death

Received: September 5, 2017; Accepted: January 4, 2018; Published: February 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kielberger L, Beneš J. Selected aspects of the management of the brain-dead organ donor. Anest. intenziv. Med. 2018;29(1):23-32.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Valentová Bartáková L, Fila L, Šimonek J, Lischke R. Transplantace plic v České republice. Postgraduální medicína. 2014;16:191-200.
    2. Zákon 44/2013, kterým se mění zákon č. 285/2002 Sb., o darování, odběrech a transplantacích tkání a orgánů a o změně některých zákonů (transplantační zákon), ve znění pozdějších předpisů, a další související zákony. In: Sbírka zákonů. 25. 2. 2013, částka 19. Dostupný z http://www.psp.cz/sqw/sbirka.sqw?cz=44&r=2013
    3. Vyhláška Ministerstva zdravotnictví ČR 115/2013 Sb., Vyhláška o stanovení specializované způsobilosti lékařů zjišťujících smrt a lékařů provádějících vyšetření potvrzující nevratnost smrti pro účely odběru tkání nebo orgánů určených pro transplantaci. In: Sbírka zákonů. 7. 5. 2013, částka 51, dostupné z http://www.psp.cz/sqw/sbirka.sqw?cz=115&r=2013
    4. Vyhláška Ministerstva zdravotnictví ČR 114/2013 Sb. Vyhláška o stanovení bližších podmínek posuzování zdravotní způsobilosti a rozsahu vyšetření žijícího nebo zemřelého dárce tkání nebo orgánů pro účely transplantací (vyhláška o zdravotní způsobilosti dárce tkání a orgánů pro účely transplantací). In: Sbírka zákonů. 7. 5. 2013, částka 51, dostupné z https://www.psp.cz/sqw/sbirka.sqw?cz=114&r=2013
    5. Sözen H, Fidan K, Mahli A, et al. Successful solid organ transplantation from septicemic cadaveric donors: case report. Transplant Proc. 2008;40:299-301. Go to original source... Go to PubMed...
    6. Nalesnik MA, Woodle ES, Dimaio JM, et al. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant. 2011;11:1140-1147. Go to original source... Go to PubMed...
    7. Ison MG, Hager J, Blumberg E, et al. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant. 2009;9:1929-1935. Go to original source... Go to PubMed...
    8. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Deceased donors with a past history of malignancy: An organ procurement and transplantation network/united network for organ sharing update. Transplantation. 2007;84:272-274. Go to original source... Go to PubMed...
    9. Feng S, Buell JF, Chari RS, DiMaio JM, Hanto DW. Tumors and transplantation: The 2003 third annual ASTS stateof-the-art winter symposium. Am J Transplant. 2003;3:148-1487. Go to original source... Go to PubMed...
    10. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti III A, eds. AJCC cancer staging manual. 7th Ed: Springer: New York, 2010.
    11. Wijdicks EF, Varelas PN, Gronseth GS, et al. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:1911-1918. Go to original source... Go to PubMed...
    12. Lévesque S, Lessard MR, Nicole PC, et al. Efficacy of a T-piece system and a continuous positive airway pressure system for apnea testing in the diagnosis of brain death. Crit Care Med. 2006;34:2213-2216. Go to original source... Go to PubMed...
    13. Hüttemann E, Schelenz C, Sakka SG, Reinhart K. Atropine test and circulatory arrest in the fossa posterior assessed by trans-cranial Doppler. Intensive Care Med. 2000;26:422-425. Go to original source... Go to PubMed...
    14. Díaz-Regañón G, Miñambres E, Holanda M, et al. Usefulness of venous oxygen saturation in the jugular bulb for the diagnosis of brain death: report of 118 patients. Intensive Care Med. 2002;28:1724-1728. Go to original source... Go to PubMed...
    15. Young GB. Diagnosis of brain death. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. Dostupné z http://www.uptodate.com/contents/diagnosis-of-brain-death#H3; 4. 1. 2016.
    16. Chisholm N, Gillett G. The patient's journey: living with locked-in syndrome. BMJ. 2005;331:94-97. Go to original source... Go to PubMed...
    17. Bugge JF. Brain death and its implications for management of the potential organ donor. Acta Anaesthesiol Scand. 2009;53:1239-1250. Go to original source... Go to PubMed...
    18. Dare AJ, Bartlett AS, Fraser JF. Critical care of the potential organ donor. Curr Neurol Neurosci Rep. 2012;12:456-465. Go to original source... Go to PubMed...
    19. Wood KE, Becker BN, McCartney JG, D'Alessandro AM, Coursin DB. Care of the potential organ donor. N Engl J Med. 2004;351:2730-2739. Go to original source... Go to PubMed...
    20. McKeown DW, Bonser RS, Kellum JA. Management of the heart-beating brain-dead organ donor. Br J Anaesth. 2012;108 Suppl 1:i96-107. Go to original source... Go to PubMed...
    21. Demetriades D, Lam L. Assessment, Monitoring, and Management of Brain-Dead Potential Organ Donors in the USA. In: Novitzky D., Cooper D. (eds.). The Brain-Dead Organ Donor. Springer: New York, 2013. Go to original source...
    22. Novitzky D, Rhodin J, Cooper DK, et al. Ultrastructure changes associated with brain death in the human donor heart. Transpl Int. 1997;10:24-32. Go to original source...
    23. Boland TA, Lee VH, Bleck TP. Stress-induced cardiomyopathy. Crit Care Med. 2015;43:686-693. Go to original source... Go to PubMed...
    24. Dujardin KS, McCully RB, Wijdicks EF, et al. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant. 2001;20:350-7. Go to original source... Go to PubMed...
    25. Shivalkar B, Van Loon J, Wieland W, et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 1993;87:230-239. Go to original source... Go to PubMed...
    26. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620-1622. Go to original source... Go to PubMed...
    27. Patel MS, Niemann CU, Sally MB, et al. The Impact of Hydroxyethyl Starch Use in Deceased Organ Donors on the Development of Delayed Graft Function in Kidney Transplant Recipients: A Propensity-Adjusted Analysis. Am J Transplant. 2015;15:2152-2158. Go to original source... Go to PubMed...
    28. Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg. 2008;85:278-286. Go to original source... Go to PubMed...
    29. Miñambres E, Rodrigo E, Ballesteros MA, et al. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation. Nephrol Dial Transplant. 2010;25:2352-2356. Go to original source... Go to PubMed...
    30. Al-Khafaji A, Elder M, Lebovitz DJ, et al. Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial. Intensive Care Med. 2015;41:418-426. Go to original source... Go to PubMed...
    31. Miñambres E, Pérez-Villares JM, Chico-Fernández M, et al. Lung donor treatment protocol in brain dead-donors: A multicenter study. J Heart Lung Transplant. 2015;34:773-780. Go to original source... Go to PubMed...
    32. Beneš J. Tekutinová terapie v intenzivní péči. Anest intenziv Med. 2016;27:107-115.
    33. Wood KE, Coursin DB. Intensivists and organ donor management. Curr Opin Anaesthesiol. 2007;20:97-99. Go to original source... Go to PubMed...
    34. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779-789. Go to original source... Go to PubMed...
    35. Callahan DS, Neville A, Bricker S, et al. The effect of arginine vasopressin on organ donor procurement and lung function. J Surg Res. 2014;186:452-457 Go to original source... Go to PubMed...
    36. Youn TS, Greer DM. Brain death and management of a potential organ donor in the intensive care unit. Crit Care Clin. 2014;30:813-831. Go to original source... Go to PubMed...
    37. Pinsard M, Ragot S, Mertes PM, et al. Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study. Crit Care. 2014;18:R158. Go to original source... Go to PubMed...
    38. Stehlik J, Feldman DS, Brown RN, et al. Cardiac Transplant Research Database Group. Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis. J Heart Lung Transplant. 2010;29:291-298. Go to original source... Go to PubMed...
    39. Novitzsky D, Cooper D, Rosendale J, Kauffman H. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation. 2006;82:1396-1401. Go to original source... Go to PubMed...
    40. Dictus C, Vienenkoetter B, Esmaeilzadeh M, Unterberg A, Ahmadi R. Critical care management of potential organ donors: our current standard. Clin Transplant. 2009;23,Suppl 21:2-9. Go to original source... Go to PubMed...
    41. Totsuka E, Dodson F, Urakami A, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg. 1999;5:421-428. Go to original source... Go to PubMed...
    42. Rech TH, Moraes RB, Crispim D, Czepielewski MA, Leitão CB. Management of the brain-dead organ donor: a systematic review and meta-analysis. Transplantation. 2013;95:966-974. Go to original source... Go to PubMed...
    43. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001;120:989-1002. Go to original source... Go to PubMed...
    44. Tien RD. Sequence of enhancement of various portions of the pituitary gland on gadolinium-enhanced MR images: correlation with regional blood supply. AJR: Am J Roentgenol. 1992;158:651-654. Go to original source... Go to PubMed...
    45. Nair-Collins M, Northrup J, Olcese J. Hypothalamic-Pituitary Function in Brain Death: A Review. J Intensive Care Med. 2016;31:41-50. Go to original source... Go to PubMed...
    46. Novitzky D, Cooper DKC, Morrell D, Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine (T3) therapy. Transplantation. 1988;45:32-36. Go to original source... Go to PubMed...
    47. Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation. 1987;43:852-854. Go to original source... Go to PubMed...
    48. Macdonald PS, Aneman A, Bhonagiri D, et al. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors. Crit Care Med. 2012;40:1635-1644. Go to original source... Go to PubMed...
    49. Kuecuek O, Mantouvalou L, Klemz R, et al. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor. Transplant Proc. 2005;37:387-388. Go to original source... Go to PubMed...
    50. Kotsch K, Ulrich F, Reutzel-Selke A et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg. 2008;248:1042-1050. Go to original source... Go to PubMed...
    51. Kainz A, Wilflingseder J, Mitterbauer C, et al. Steroid pre-treat-ment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial. Ann Intern Med. 2010;153:222-230. Go to original source... Go to PubMed...
    52. Dupuis S, Amiel JA, Desgroseilliers M, et al. Corticosteroids in the management of brain-dead potential organ donors: a systematic review. Br J Anaesth. 2014;113:346-359. Go to original source... Go to PubMed...
    53. United Network for Organ Sharing. Critical pathway for the organ donor. Dostupné z www.unos.orgorg/wp-content/uploads/unos/Critical_Pathway.pdf. 15. 6. 2017.
    54. Niemann CU, Feiner J, Swain S, el al. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med. 2015;373:405-414. Go to original source... Go to PubMed...
    55. Bhorade, SM, Vigneswaran, W, McCabe, MA, Garrity, ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000;19:1199. Go to original source... Go to PubMed...
    56. Pêgo-Fernandes PM, Samano MN, Fiorelli AI, et al. Recommendations for the use of extended criteria donors in lung transplantation Transplant Proc. 2011;43:216-219. Go to original source... Go to PubMed...
    57. Reilly PM, Grossman MD, Rosengard BR, et al. Lung procurement from solid organ donors: role of fluid resuscitation in procurement failures. Chest. 1996;110:222S.
    58. Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304:2620-2627. Go to original source... Go to PubMed...
    59. Migliaccio ML, Zagli G, Cianchi G, et al. Extracorporeal membrane oxygenation in brain-death organ and tissues donors: a single-centre experience. Br J Anaesth. 2013;111:673-674. Go to original source... Go to PubMed...
    60. Shah V, Lazaridis C. Apnea testing on extracorporeal membrane oxygenation: Case report and literature review. J Crit Care. 2015;30:784-786. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.